Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Erik Aerts, RN, Hematology Nurses and Healthcare Professionals Group, Winterthur, Switzerland, details the topics discussed during the group discussion on the ethics of CAR T-cell therapy. The group debated how patients are affected by the burden of treatment and the costs of CAR T-cell therapy. This interview took place during the 3rd European CAR T-cell Meeting.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.